- CE Marked
- 17 Analytes Available
- Human Serum Matrix
- Liquid, Ready-to-Use
-
Serum Proteins Linearity Verification and Calibration Kits View the multiple range coverages for each analyte and identify the recommended products for your specific clinical analyser. -
Therapeutic Drug Monitoring Linearity Verification and Calibration Kits View the multiple range coverages for each analyte and identify the recommended products for your specific clinical analyser.- CE Marked
- 17 Analytes Available
- Human Serum Matrix
- Liquid, Ready-to-Use
-
Thyroid Linearity Verification and Calibration Kits View the multiple range coverages for each analyte and identify the recommended products for your specific clinical analyser.- CE Marked
- 7 Analytes Available
- Human Serum Matrix
- Liquid, Ready-to-Use
-
Tumour Markers Linearity Verification and Calibration Kits View the multiple range coverages for each analyte and identify the recommended products for your specific clinical analyser.- CE Marked
- 6 Analytes
- Human Serum Matrix
- Liquid, Ready-to-Use
-
Urine Chemistry Linearity Verification and Calibration Kits View the multiple range coverages for each analyte and identify the recommended products for your specific clinical analyser.- CE Marked
- 15 Analytes Available
- Liquid, Ready-to-Use
-
Newborn screening platform powered by digital microfluidics SEEKER® is a newborn screening laboratory solution that performs multiple assays at the same time using just one punch from a newborn dried blood spot specimen. SEEKER® is used to test thousands of babies each day around the world. Lysosomal Storage Disorders SEEKER® is the first FDA-authorised and CE-marked newborn screening platform for lysosomal storage disorders. SEEKER® quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens. Reduced activity of these enzymes may be indicative of: MPS I • Pompe • Gaucher • Fabry -
Positive quality control for antibodies to SARS-CoV-2 (including IgG) Multichem ID-COVID19 G is an unasssayed third-party quality control for Antibodies to SARS-CoV-2 (including IgG). This Quality Control is available with access to the Technopath Clinical Diagnostics inter-laboratory Peer program, IAMQC®. The Multichem ID-COVID19 G (unassayed) is a positive control for antibodies to the SARS-CoV-2 virus (including IgG). The kit is delivered in a choice of two configurations: 4x2mL tubes with an integrated instrument barcode and secondly 4 x 4mL vials. The product is suitable for use on all major platforms, including amongst others, Abbott, Roche and Siemens. All Multichem ID-COVID19 quality controls are supported by the inter-laboratory Peer program - IAMQC®. -
Negative quality control for antibodies to SARS-CoV-2 (including IgG) Multichem ID-COVID19Neg is an unassayed negative third-party quality control for antibodies to SARS-CoV-2 (including IgG). This Quality Control is available with access to the Technopath Clinical Diagnostics inter-laboratory Peer program, IAMQC®. The Multichem ID-COVID19Neg (unassayed) is an unassayed negative third-party quality control for antibodies to SARS-CoV-2 (including IgG). The kit is delivered in a choice of two configurations: 4x2mL tubes with an integrated instrument barcode and secondly 4 x 4mL vials. The product is suitable for use on all major platforms, including amongst others, Abbott, Roche and Siemens. All Multichem ID-COVID19 quality controls are supported by the inter-laboratory Peer program - IAMQC®. -
Negative multi-marker QC Multichem Infectious Disease (ID) Quality Controls (QC) samples, have been specifically optimised and validated to match assays commonly used for infectious diseases testing. Multichem ID-SeroNeg provides a negative control for the analytes listed below. Scroll down to view the product benefits and analyte list. Multichem ID SeroNeg provides a third party, unassayed, negative control for commonly tested assays for anti-HIV, anti-HCV, anti HTLV, anti-HBc, anti-Treponema, HBsAg and HIVp24 -
Positive multi-marker QC Multichem Infectious Disease (ID) Quality Controls (QC) samples, have been specifically optimised and validated to match assays commonly used for infectious diseases testing. Multichem ID-B is an unassayed control, optimised for Abbott and Diasorin instruments. Scroll down to view the product benefits and analyte list. The Multichem ID Multi-marker range of products is easily identifiable by their colour coding (in this case B for blue). Multichem ID-B consolidates six analytes (see analyte list below). This unassayed product is optimised for specific platforms, including; Abbott Architect, Abbott Alinity i, Abbott Alinity s, DiaSorin Liaison, DiaSorin Liaison XL MUREX. -
Clinical Diagnostic Quality Solutions for SARS-CoV-2 Variant Analysis AccuPlex SARS-CoV-2 Variant Panel 1 contains the full SARS-CoV-2 genomic RNA with a focus on S-gene mutations (Table 1) in three prominent variants of concern (VOC): UK variant B.1.1.7, South Africa variant B.1.351, and Brazil variant P.1. The kit has one vial for each variant as well as a fourth wild type (reference sequence NC_045512) control vial. An RNase P negative control vial is also included.- Performance confirmation of existing SARS-CoV-2 molecular assays with different variants
- Reference materials for SARS-CoV-2 variant genotyping assays
- Reference materials for SARS-CoV-2 NGS assays
- Non-infectious and replication deficient, enables safe handling of positive material
- Fully extractable with a real viral protein coat; superior to “naked” transcribed RNA
- 2 year stability at 2 - 8°C
-
Ensure antibody testing accuracy and performance To support the many SARS-CoV-2 serology assay formats available, the kit is currently offered in two configurations, one designed for IgG-specific assays and the other for total antibody tests. Series 1000 is released using the Abbott ARCHITECT SARS-CoV-2 IgG assay, and Series 2000 is released using the Roche cobas® Elecsys® Anti-SARS-CoV-2 assay. Reference materials are specifically formulated to exhibit low positive reactivity in true patient-like matrices, to test assay performance near critical signal cutoff boundaries. AccuSet™ SARS-CoV-2 Performance Panel is intended to provide an out-of-the-box solution to evaluate SARS-CoV-2 antibody detection assays with highly characterised human specimens whether generating validation data for a regulatory submission or performing assay verification in a clinical laboratory setting.